Coronary microvascular dysfunction clinical trials
10 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Improving Coronary Vascular Health in Women
- Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease
- Mental Stress Reactivity in Women With CMD
- The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease
- A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
- Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution
- Coronary Microvascular Disease (CMD) Registry
- Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
- WISE CVD - Continuation (WISE HFpEF)
- Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Coronary microvascular dysfunction” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.